Aran Research & Development (1982) Ltd. (ARAN)의 가격은 얼마입니까?

Aran Research & Development (1982) Ltd. (ARAN)의 가격은 $14.88입니다.

Aran Research & Development (1982) Ltd. (ARAN)의 시가 총액은 무엇입니까?

Aran Research & Development (1982) Ltd. (ARAN)의 시가 총액은 $672.76K입니다.

Aran Research & Development (1982) Ltd. (ARAN) 액면분할

Aran Research & Development (1982) Ltd., an Israeli company founded in Caesarea in 1982, specializes in the design, development, and manufacturing of various products and equipment, with a significant focus on the plastics industry within Israel. The company boasts a broad portfolio, encompassing a wide array of medical devices such as cardiovascular solutions, in-vitro diagnostic tools, surgical instruments, and advanced imaging and monitoring systems. They are also prominent in fluid management, producing water devices like pressure and flow regulators, a variety of valves (electric, hydraulic, air release, check), sprinklers, drippers, taps, water meters, filters, electronic controllers, and specialized testing equipment. Beyond these core areas, Aran provides portable and stationary control systems for unmanned platforms, electro-optical technologies, and robust electronic hardware engineered for demanding ground, marine, and aerial environments. Their offerings extend to ground systems for security and access control, test and measurement equipment, and production line facilities. The company further manufactures specialized printers, automatic beverage dispensers, sophisticated retail technology like computerized shopping carts and self-checkout kiosks, industrial and communication devices, and batteries. Additionally, Aran acts as a supplier for crucial machinery and components, including injection molding machines, robotics and automation systems, injection molds, hot runner systems, drying, dosing, and conveying systems, plasticizing screws and barrels, and ultrasonic welding and cleaning equipment, along with raw materials. The firm also delivers comprehensive support services and makes strategic investments in emerging medical technology startups.